PUBLISHER: The Business Research Company | PRODUCT CODE: 1945216
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945216
Foot drop treatment devices are specialized medical aids designed to help individuals with foot drop, a condition characterized by difficulty lifting the front part of the foot, often caused by neurological or muscular disorders. These devices work by supporting the foot in an elevated position, preventing it from dragging or slapping during walking. The goal of foot drop treatment devices is to improve mobility, reduce the risk of falls, and enhance the quality of life for those affected by the condition.
The primary types of foot drop treatment devices include electrical stimulators and braces or splints. An electrical stimulator is a device that delivers electrical impulses to stimulate nerves or muscles. It is used to treat conditions such as neuropathy, muscle disorders, brain and spinal disorders, among others. These devices are commonly used in hospitals, ambulatory surgical centers, clinics, and home care settings.
Tariffs are influencing the foot drop treatment devices market by increasing costs of imported electronic components, sensors, batteries, specialized polymers, and precision manufacturing equipment used in stimulators and orthotic braces. Healthcare providers in North America and Europe are most affected due to reliance on imported rehabilitation devices, while Asia-Pacific faces higher production costs for export-oriented manufacturing. These tariffs are raising device prices and impacting reimbursement-sensitive markets. However, they are also driving localized assembly, domestic component sourcing, and innovation in cost-effective and patient-friendly mobility solutions.
The foot drop treatment devices market research report is one of a series of new reports from The Business Research Company that provides foot drop treatment devices market statistics, including foot drop treatment devices industry global market size, regional shares, competitors with a foot drop treatment devices market share, detailed foot drop treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the foot drop treatment devices industry. This foot drop treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The foot drop treatment devices market size has grown strongly in recent years. It will grow from $2.45 billion in 2025 to $2.65 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing incidence of neurological disorders, rising cases of stroke-related mobility impairment, expansion of rehabilitation centers, growing availability of orthotic devices, increased clinical awareness of foot drop management.
The foot drop treatment devices market size is expected to see strong growth in the next few years. It will grow to $3.59 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing adoption of advanced neurorehabilitation technologies, rising demand for homecare mobility aids, expansion of personalized orthotic solutions, growing focus on improving quality of life, technological advancements in wearable medical devices. Major trends in the forecast period include increasing adoption of functional electrical stimulation devices, rising demand for custom-fitted orthotic braces, growing use of lightweight and flexible materials, expansion of home-based rehabilitation solutions, enhanced focus on patient mobility improvement.
The growing incidence of neurological disorders and injuries is anticipated to drive the expansion of the foot drop treatment devices market. Neurological disorders and injuries refer to conditions that impact the brain, spinal cord, and nerves, leading to impairments in motor skills, sensation, cognition, or behavior due to damage, disease, or degeneration of the nervous system. Factors contributing to the rise in these conditions include an aging population, increased awareness and diagnosis, lifestyle factors, environmental influences, and medical advancements that improve detection and treatment. Foot drop treatment devices are crucial for individuals affected by neurological disorders and injuries, as these conditions often impair the ability to lift the foot, making walking difficult and increasing the risk of falls. These devices provide essential support and stability, helping lift the foot and improving mobility, thus enhancing the quality of life. For example, in October 2023, the World Federation of Neurology, based in the UK, reported that over 40% of the global population is affected by some neurological condition, and this figure is expected to nearly double by 2050. As a result, the increasing prevalence of neurological disorders and injuries is fueling the growth of the foot drop treatment devices market.
Major players in the foot drop treatment devices market are emphasizing technological innovations, such as software-powered, wearable bionic clothing that combines functional electrical stimulation with real-time mobility tracking, to enhance walking, strength, and independence for individuals with neuromuscular impairments. Software-powered wearable bionic devices enable personalized functional training, detailed progress monitoring, and integration into daily activities, helping patients regain mobility, climb stairs, walk, and perform essential tasks more independently. For example, in May 2024, CIONIC, a US-based neurotechnology company, introduced updates to its FDA-cleared Cionic Neural Sleeve, adding new functional exercises and comprehensive activity tracking reports for patients with multiple sclerosis, strokes, spinal cord injuries, and other upper motor neuron conditions. The lightweight, durable leg sleeve integrates gait lab diagnostics with functional electrical stimulation and is smartphone-controlled, allowing software-driven updates to be deployed to all users simultaneously, empowering patients to improve functional mobility and daily independence.
In January 2024, OrthoPediatrics, a US-based medical device company, acquired Boston Orthotics & Prosthetics in a $22 million deal. This acquisition is expected to strengthen OrthoPediatrics' Specialty Bracing division, which focuses on non-surgical treatment options for children with orthopedic conditions. Boston Orthotics & Prosthetics, also based in the US, manufactures devices for the treatment of foot drop, specializing in the production of ankle-foot orthotics.
Major companies operating in the foot drop treatment devices market are Cardinal Health Inc., Stryker Corporation, Henry Schein Inc., Smith & Nephew LLC, Ottobock, Hanger Inc., Ossur, Bauerfeind USA Inc., Breg Inc., B. Braun Melsungen AG, Trulife Ltd., Orthomerica Products Inc., Bioness Inc., Evolution Health Care Pvt. Ltd., Aspen Medical Products, Allard Inc., Footmaxx, ProCare, DJO Global Inc., ALIMCO, Saebo Inc., Axio Bionics LLC, Thrive Orthopedics, Turbomed Orthotics, Accord Medical Products Private Limited
North America was the largest region in the foot drop treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the foot drop treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the foot drop treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The foot drop treatment devices market consists of sales of ankle-foot orthoses, toe lift assist devices, exoskeletons for lower limb support, and foot drop shoe inserts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Foot Drop Treatment Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses foot drop treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for foot drop treatment devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The foot drop treatment devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.